Skip to main content
SpringerLink
Log in

Control of Cancer Pain with Analgesics Acting in the Central Nervous System

  • Conference paper
Pain in the Cancer Patient

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 89))

Abstract

Optimal control of cancer pain requires that the problem of pain be accorded a significance of its own and that it is seen in its complexity. In the context of advanced metastatic malignancies, pain is not only a symptom but also a force with a series of pathophysiologic, psychopathologic, and social consequences (Bonica 1979). Facultatively, we find muscular tension, immobility, disturbances of respiratory and cardiovascular function, inhibition of gastrointestinal motility, disorders of sleep, depressed mood, and misanthropic behavior extending to lamentation, moaning, and crying. These effects of pain may be negatively combined with other manifestations of cancer. For example, lack of appetite due to malignancy can be intensified by pain and thus may contribute to the progress of cachexia by inadequate food intake. In therapy, besides the pathophysiology of pain, its sequelae as well as its psychodynamics and the behavior of the patient have thus also to be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Arend J, von Arnim B, Nijssen J, Scheele J, Flohé L (1978) Tramadol und Pentazocin im klinischen Doppelblind-Crossover-Vergleich. Arzneim Forsch Drug Res 28: 199–208

    CAS  Google Scholar 

  • Beaver WT, Wallenstein SL, Houde RW, Rogers A (1966) A comparison of the analgesic effects of pentazocine and morphine in patients with cancer. Clin Pharmacol Ther 7: 740–751

    PubMed  CAS  Google Scholar 

  • Bonica JJ (1979) Importance of the problem. In: Bonica JJ, Ventafridda V (eds) Advances in pain research and therapy, vol 2 Raven, New York, pp 1–12

    Google Scholar 

  • Brauchle W (1971) Erfahrungen mit einem neuen Depot-Analgetikum (Develin retard). Z Allgemeinmed 47: 1465–1467

    PubMed  CAS  Google Scholar 

  • Cabanne F, Guerrin J, Wilkening M (1972) Die Behandlung von Tumorschmerzen mit Pentazocin. In: Janzen R, Keidel WD, Herz A, Steichele C (eds) Pain. Thieme, Stuttgart, pp 444–446

    Google Scholar 

  • Cronheim G, Thiede W (1979) Ergebnisse einer Feldstudie mit Nefopam. In: Gerbershagen HU, Cronheim G (eds) Nefopam. Ein neuartiges Analgetikum. Fischer, Stuttgart, pp 142–147

    Google Scholar 

  • De Thibault de Boesinghe L (1978) Double blind study of the analgesic effect of nefopam hydrochloride (Acupan) and pentazocine (Fortral) in cancer patients with pain. Curr Ther Res 24: 646–655

    Google Scholar 

  • Eckmann F, Kubicki SK, Mazaheri P (1975) Zur Frage einer Pentazocin-Abhängigkeit. In: Neuhaus GA, Kubicki SK (eds) Pentazocin, ein neuer Weg. Thieme, Stuttgart, pp 61–64

    Google Scholar 

  • Flohé L, Arend J, Cogal A, Richter W, Simon W (1978) Klinische Prüfungen der Langzeitapplikation von Tramadol. Arzneim Forsch Drug Res 28: 213–217

    Google Scholar 

  • Foley KM (1976) Pain syndromes in patients with cancer. In: Bonica JJ, Ventafridda V (eds) Advances in pain research and therapy, vol 2. Raven, New York, pp 59–78

    Google Scholar 

  • Frankendahl B, Kjellgren O (1971) Severe pain in gynecologic cancer. Cancer 27: 842–847

    Article  Google Scholar 

  • Frutschnigg E (1973) Schmerzbehandlung bei Karzinomen. Aerztl Praxis 25: 4429–4432

    Google Scholar 

  • Groh R, Schindera A, Werringloer M (1971) Klinische Erfahrungen mit dem neuen Analgetikum Tilidin-HCL. Med Klinik 66: 1241–1245

    CAS  Google Scholar 

  • Hoffmeister F (1968) Untersuchungen über die analgetischen, morphinantagonistischen und morphinartigen Wirkungen von Morphinantagonisten an normalen und morphinabhängigen Tieren. Pharmakopsychiatrie 1: 239–260

    Article  CAS  Google Scholar 

  • Houde RW (1979) Systemic analgesics and related drugs: Narcotic analgesics. In: Bonica JJ, Ventafridda V (eds) Advances in pain research and therapy, vol 2. Raven, New York, pp 263–273

    Google Scholar 

  • Jaffe JH, Martin WR (1980) Opoid analgesics and antagonists. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics. MacMillan, New York, pp 494–534

    Google Scholar 

  • Kleibel F (1972) Erfahrungen mit Pentazocin in der klinischen Onkologie. In: Janzen R, Keidel WD, Herz A, Steichele C (eds) Pain. Thieme, Stuttgart, pp 446–448

    Google Scholar 

  • Krell R, Hanke M (1979) Klinische Prüfung der analgetischen Wirksamkeit von Valoron N im Vergleich zu Valoron bei Tumorschmerzen. Krankenhausarzt 52: 760–764

    Google Scholar 

  • Robbie DS (1979) A trial of sublingual buprenorphine in cancer pain. Br J Clin Pharmacol 7: 3155–3175

    Google Scholar 

  • Schietzl M (1979) Nefopamhydrochlorid, ein neuartiges Analgetikum mit geringen Nebenwirkungen. In: Gerbershagen HU, Cronheim G (eds) Nefopam. Ein neuartiges Analgetikum. Fischer, Stuttgart, pp 129–131

    Google Scholar 

  • Twycross RG (1980) Overview of analgesia. In: Bonica JJ, Ventafridda V (eds) Advances in pain research and therapy, vol 2. Raven, New York, pp 617–633

    Google Scholar 

  • Vere DW (1978) Pharmacology of morphine drugs in terminal care. In: Vere DW (ed) Topics in therapeutics 4. Pitman, London, pp 75–83

    Google Scholar 

  • Zimmermann M (1979) Neurophysiologische Untersuchungen über einen spinalen Wirkungsort von Nefopam. In: Gerbershagen HU, Cronheim G (eds) Nefopam. Ein neuartiges Analgetikum. Fischer, Stuttgart New York, pp 18–26

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Schmerz-Zentrum Mainz, Auf der Steig 14-16, 6500, Mainz, Germany

    R. Wörz

Authors
  1. R. Wörz
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. II. Physiologisches Institut, Universität Heidelberg, Im Neuenheimer Feld 326, 6900, Heidelberg 1, Germany

    Manfred Zimmermann

  2. Klinik für Thoraxerkrankungen der Landesversicherungsanstalt Baden, Krankenhaus Rohrbach, Amalienstrasse 5, 6900, Heidelberg 1, Germany

    Peter Drings

  3. Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, 6900, Heidelberg 1, Germany

    Gustav Wagner

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Wörz, R. (1984). Control of Cancer Pain with Analgesics Acting in the Central Nervous System. In: Zimmermann, M., Drings, P., Wagner, G. (eds) Pain in the Cancer Patient. Recent Results in Cancer Research, vol 89. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82028-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-82028-1_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-82030-4

  • Online ISBN: 978-3-642-82028-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation